In vitro efficacy of a synthetic all-d antimicrobial peptide against clinically isolated drug-resistant strains.
Park
Yoonkyung
Y
Park
Seong-Cheol
SC
Kim
Jin-Young
JY
Park
Jeong Ok
JO
Seo
Chang Ho
CH
Nah
Jae-Woon
JW
Hahm
Kyung-Soo
KS
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D023181:Antimicrobial Cationic Peptides / Q000235:genetics / Q000494:pharmacology*; D001419:Bacteria / Q000302:isolation & purification*; D001424:Bacterial Infections / Q000382:microbiology*; D005260:Female; D006761:Hospitals; D006801:Humans; D008826:Microbial Sensitivity Tests; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000494:pharmacology; D056910:Republic of Korea; D029867:Xenopus Proteins / Q000235:genetics / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D023181:Antimicrobial Cationic Peptides; D011993:Recombinant Fusion Proteins; D029867:Xenopus Proteins; C053300:magainin 1 peptide, Xenopus; C031161:cecropin A